Drug that restricts blood supply to prostate tumours delays disease progression
Wednesday, June 9, 2010 - 07:01
in Health & Medicine
A blood vessel-blocking drug called tasquinimod slowed the rate of disease progression in a clinical trial of 200 prostate cancer patients, according to experts at Johns Hopkins, Roswell Park Cancer Institute and Duke University...
